Mark Reddish
Direttore operativo presso Metrodora Therapeutics, Inc.
Profilo
Mark Reddish is currently working as Vice President-Operation at Metrodora Therapeutics, Inc. He previously worked as Senior Director-Research Immunology at Biomira, Inc. from 1991 to 1998, Vice President-Product Development at ID Biomedical Corp.
from 1998 to 2005, and as an Independent Director at Marker Therapeutics, Inc. from 2014 to 2018.
He completed his undergraduate degree from the University of Massachusetts.
Posizioni attive di Mark Reddish
| Società | Posizione | Inizio |
|---|---|---|
| Metrodora Therapeutics, Inc. | Direttore operativo | - |
Precedenti posizioni note di Mark Reddish
| Società | Posizione | Fine |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 17/10/2018 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 01/01/2005 |
Biomira, Inc.
 Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | Corporate Officer/Principal | 01/01/1998 |
Formazione di Mark Reddish
| University of Massachusetts | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MARKER THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
| Metrodora Therapeutics, Inc. | |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Health Technology |
Biomira, Inc.
Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | Health Services |
- Borsa valori
- Insiders
- Mark Reddish
